QTR’s Fringe Finance • 42 implied HN points • 24 Mar 26
- Some GLP-1 weight-loss drugs like Ozempic, Wegovy, and Rybelsus have been linked to a rare but serious eye condition (NAION) that can cause sudden vision loss.
- The risk for any one person is small (roughly 1 in 10,000), but with millions using these drugs the total number of affected people could be substantial, and higher doses or faster weight loss may raise the risk.
- New drugs often arrive with a lot of hype but can reveal serious side effects over time, so patients and doctors should weigh benefits against rare harms and make informed choices.